Literature DB >> 16460957

G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation.

Shai Gavi1, Elena Shumay, Hsien-yu Wang, Craig C Malbon.   

Abstract

G-protein-coupled receptors and protein tyrosine kinases represent two prominent pathways for cellular signaling. As our knowledge of cell signaling pathways mediated by the superfamily of G-protein-coupled receptors and the smaller family of receptor tyrosine kinases expands, so does our appreciation of how these two major signaling platforms share information and modulate each other, otherwise termed "cross-talk". Cross-talk between G-protein-coupled receptors and tyrosine kinases can occur at several levels, including the receptor-to-receptor level, and at crucial downstream points (e.g. phosphatidylinositol-3-kinase, Akt/protein kinase B and the mitogen-activated protein kinase cascade). Regulation of G-protein-coupled receptors by non-receptor tyrosine kinases, such as Src family members, also operates in signaling. A broader understanding of how G-protein-coupled receptors and tyrosine kinases cross-talk reveals new insights into signaling modalities in both health and disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460957     DOI: 10.1016/j.tem.2006.01.006

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  36 in total

Review 1.  Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

Authors:  C Hawkes; A Amritraj; R G Macdonald; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 2.  Melanocyte receptors: clinical implications and therapeutic relevance.

Authors:  J Andrew Carlson; Gerald P Linette; Andrew Aplin; Bernard Ng; Andrzej Slominski
Journal:  Dermatol Clin       Date:  2007-10       Impact factor: 3.478

Review 3.  G-protein-coupled receptor phosphorylation: where, when and by whom.

Authors:  A B Tobin
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

Review 4.  Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking.

Authors:  Verónica Alonso; Peter A Friedman
Journal:  Mol Endocrinol       Date:  2013-03-07

Review 5.  Novel tyrosine kinase signaling pathways: implications in vascular remodeling.

Authors:  Sri N Batchu; Vyacheslav A Korshunov
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

6.  Primary Cilia Signaling Promotes Axonal Tract Development and Is Disrupted in Joubert Syndrome-Related Disorders Models.

Authors:  Jiami Guo; James M Otis; Sarah K Suciu; Christy Catalano; Lei Xing; Sandii Constable; Dagmar Wachten; Stephanie Gupton; Janice Lee; Amelia Lee; Katherine H Blackley; Travis Ptacek; Jeremy M Simon; Stephane Schurmans; Garret D Stuber; Tamara Caspary; E S Anton
Journal:  Dev Cell       Date:  2019-12-16       Impact factor: 12.270

7.  Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes.

Authors:  Sergey Missan; Paul Linsdell; Terence F McDonald
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

8.  Cocaine- and amphetamine-regulated transcript accelerates termination of follicle-stimulating hormone-induced extracellularly regulated kinase 1/2 and Akt activation by regulating the expression and degradation of specific mitogen-activated protein kinase phosphatases in bovine granulosa cells.

Authors:  Aritro Sen; Lihua Lv; Nora Bello; James J Ireland; George W Smith
Journal:  Mol Endocrinol       Date:  2008-09-25

Review 9.  Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors:  Maya B Lodish
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

Review 10.  Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling.

Authors:  Andrew B Tobin; Adrian J Butcher; Kok Choi Kong
Journal:  Trends Pharmacol Sci       Date:  2008-07-06       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.